Sensory complaints of the upper extremities in multiple sclerosis: Relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation

Clinical Journal of Pain

Volumn 25, Issue 4, 2009, Pages 281-285

  Chitsaz, Ahmad ^a   Janghorbani, Mohsen ^b,c   Shaygannejad, Vahid ^a   Ashtari, Fereshteh ^b   Heshmatipour, Mojtaba ^c   Freeman, Jennifer ^d  

^a Medical School

^b School of Public Health   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Efficacy; Multiple sclerosis; Nortriptyline; Pain; Sensory complaints; Transcutaneous electrical nerve stimulation

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NAUSEA; PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSORY DYSFUNCTION; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT RESPONSE; URINE RETENTION; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 67649550744     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318190862b     Document Type: Article

References (42)

1. Clanet MG, Brassat D. The management of multiple sclerosis patients. Curr Opin Neurol. 2000;13:263-270.
2. Richards RG, Sampson FC, Beard SM, et al. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess. 2002;6:1-73.
3. Davis WM. Multiple sclerosis: continuing mysteries and current management. Drug Topics. 2000;144:93-102.
4. Polman CH, Uitdehaag BMJ. Drug treatment of multiple sclerosis. BMJ. 2000;321:490-494.
5. Charcot JM. Lecon sur les Maladies du Systeme Nerveux Faites a la Salpetrier Paris. 2nd ed. Paris: 1872:239-240.
6. Beiske AG, Pedersen ED, Czujko B, et al. Pain and sensory complaints in multiple sclerosis. Eur J Neurol. 2004;11:479-482.
7. Osterberg A, Boivie J, Thuomas K-A. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain. 2005;9:531-542.
8. Svendsen KB, Jensen TS, Overvad K, et al. Pain in patients with multiple sclerosis. Arch Neurol. 2003;60:1089-1094.
9. Archibald CJ, McGrath PJ, Rivito PG, et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain. 1994;58:89-93.
10. Stenager E, Knutsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand. 1991;84: 197-200.
11. Moulin DE, Foley KM, Ebers GC. Pain syndromes in multiple sclerosis. Neurology. 1988;38:1830-1834.
12. Kerns RD, Kassirer M, Otis J. Pain in multiple sclerosis: a biopsychosocial perspective. J Rehabil Res Dev. 2002;39: 225-233.
13. Leary S, Thompson A. Current management of multiple sclerosis. Int J Clin Pract. 2000;54:161-169.
14. Howarth A. Pain management for multiple sclerosis patients. Prof Nurse. 2000;16:824-826.
15. Cohen H, Cohen MR. Nortriptyline and neuropathic pain. Nurse Pract. 1999;24:124.
16. Max MB. Antidepressants as analgesics. In: Fields HL, Liebeskind JC, ed. Progress in Pain Research and Management. Vol 1. Seattle: IASP Press; 1994:229-246.
17. Spiegel K, Kalb R, Pasternak W. Analgesic activity of tricyclic antidepressants. Ann Neurol. 1983;13:462-465.
18. Seltzer Z, Tal M, Sharav Y. Autonomy behavior in rats following peripheral deafferentation is suppressed by daily injection of amitriptyline, diazepam, and saline. Pain. 1989;37:245-250.
19. Goodkin K, Gullion CM. Antidepressants for the relief of chronic pain: do they work? Ann Behav Med. 1989;11:83-101.
20. Onghena P, Van Houdenhove B. Antidepressant induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 1992;49:205-219.
21. Atkinson JH, Slater MA, Doctor JN, et al. Psychopharmacologic agents in the treatment of pain. In: Tollison CD, Satterthwaite JR, Tollison JW, ed. Handbook of Pain Management. 2nd ed. Baltimore: Williams and Wilkins; 1993:181-214.
22. Turner JA, Denny MC. Do antidepressant medications relieve chronic low back pain? J Fam Pract. 1993;37:545-553.
23. Miller L, Mattison P, Paul L, et al. The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis. Multiple Sclerosis. 2007;13:527-533.
24. Ellis B. Transcutaneous electrical nerve stimulation for pain relief: recent research findings and implications for clinical use. Phys Ther Rev. 1998;3:3-8.
25. Cheng RSS, Pomeranz B. Electrotherapy of chronic musculoskeletal pain: comparison of electroacupuncture and acupuncture- like transcutaneous electrical nerve stimulation. Clin J Pain. 1987;2:143-149.
26. Gersh M, Wolf S. Application of transcutaneous electrical nerve stimulation in the management of patients with pain. Phys Ther. 1985;65:314-319.
27. Warke K, Al-Smadi J, Baxter GD, et al. Use of self-applied TENS for low back pain in people with multiple sclerosis. Int J Ther Rehabil. 2004;11:275-280.
28. Warke K, Al-Smadi J, Baxter D, et al. Efficacy of transcutaneous electrical nerve stimulation (tens) for chronic low-back pain in a multiple sclerosis population: a randomized, placebocontrolled clinical trial. Clin J Pain. 2006;22:812-819.
29. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guideline for research protocol. Ann Neurol. 1983;13:227-231.
30. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
31. Low J, Reed A. Electrotherapy Explained: Principle and Practice. 3rd ed. Oxford: Butterworth-Heinemann; 2000:53-140.
32. Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
33. Atkinson JH, Slater MA, Williams RA, et al. A placebocontrolled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998;76:287-296.
34. Marchand S, Charest J, Li J, et al. Is TENS purely a placebo effect? A controlled study on chronic low back pain. Pain. 1994;56:122.
35. Moore SR, Shurman J. Combined neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation for treatment of chronic back pain: a double-blind, repeated measures comparison. Arch Phys Med Rehabil. 1997;78: 55-60.
36. Al-Smadi J, Warke K, Wilson I, et al. A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis. Clin Rehabil. 2003;17:742-749.
37. Brosseau L, Milne S, Robinson V, et al. Efficacy of the transcutaneous electrical nerve stimulation for the treatment of chronic low back pain: a meta-analysis. Spine. 2002;27:596-603.
38. Robinson I. Managing multiple sclerosis: a partnership between professional practitioners and patients. In: De Souza L, ed. Multiple Sclerosis; Approaches to Management. London: Chapman and Hall; 1990:1-16.
39. Ainsworth L, Budelier K, Clinesmith M, et al. Transcutaneous electrical nerve stimulation (TENS) reduces chronic hyperalgesia induced by muscle inflammation. Pain. 2006;120: 182-187.
40. Melzak R, Wall PD. Pain mechanism: a new theory. Science. 1965;150:171-179.
41. Schultz K, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimension of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
42. Dworkin RH, Turk DC, Farrar JT, et al. IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19.